A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.

Commun Biol · 2023 · PMC10507044 · PMID 37723198

Europe PMC DOI

hedged sentences

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp = 5.48e−10actually significant

Highly significant similarity ( p = 5.48e−10) was found comparing matched patient primary tumor-PDX to randomly selected pairs (Fig. 6b ).

also in 26,558 other papers

an interesting trendno p-value reported

S3e ) in mice despite an interesting trend in osteosarcoma to cluster together suggesting a partial reconstitution of osteosarcoma microenvironment in PDX.

also in 497 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.